23 - Romiplostim in Low/INT-1-Risk MDS Results in Reduced Bleeding without Impacting Leukemic Progression: Final Results from a Randomized, Double-Blind, Placebo-Controlled Study

Journal article

Peer reviewed

H. Kantarjian, P. Fenaux, M. Sekeres, J. Szer, U. Platzbecker, A. Kuendgen, G. Gaidano, W.W. Jedrzejczak, N. Carpenter, B. Mehta, …

Leukemia research, Vol.55, pp.S12-S14

2017-04

Metrics

1 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.103 Blood Disorders; 1.103.155 Acute Myeloid Leukemia
Web Of Science research areas: Hematology; Oncology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: 23 - Romiplostim in Low/INT-1-Risk MDS Results in Reduced Bleeding without Impacting Leukemic Progression: Final Results from a Randomized, Double-Blind, Placebo-Controlled Study
Creators: H. Kantarjian
P. Fenaux
M. Sekeres
J. Szer
U. Platzbecker
A. Kuendgen
G. Gaidano
W.W. Jedrzejczak
N. Carpenter
B. Mehta
J. Franklin
A. Giagounidis
Publication Details: Leukemia research, Vol.55, pp.S12-S14
Publisher: Elsevier Ltd
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031757882902976